April 12, 2024
Small Scale Bioreactors Market

Small Scale Bioreactors Market is Estimated to Witness High Growth Owing to Rising R&D Spending for Biotechnology Products

Small scale bioreactors also known as benchtop bioreactors are used for cell cultivation at a small volume scale ranging from milliliters to few liters. They offer various advantages over shake flasks such as precise control over critical process parameters, integrated data acquisition, and automation capabilities. The need for small scale bioreactors has increased in biopharmaceutical industry due to their applications in process development, quality control testing, and clinical trial material manufacturing. They help optimize scale-up strategies for large industrial fermenters.

The Global Small Scale Bioreactors Market Demand is estimated to be valued at US$ 1738.21 Mn in 2024 and is expected to exhibit a CAGR of 3.8% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the small scale bioreactors are LabCorp, Quest Diagnostics, Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMérieux SA, DiaSorin S.p.A, T2 Biosystems, Inc., F. Hoffmann-La Roche AG, Meridian Bioscience, Inc., Quidel Corporation, and Thermo Fisher Scientific Inc.

The market offers huge opportunities for biotech startups working on novel biologics due to low capital investment required for small scale bioreactors as compared to large industrial fermenters. Rising demand for personalized medicine will further aid market growth.

Globally, North America dominates the market due to major biopharma companies based in the region and increasing R&D activities. However, Asia Pacific is expected to witness highest CAGR during the forecast period on back of growing biosimilar industry in India and China.

Market drivers

Rising spending on research and development activities by biotech and pharmaceutical companies is a major driver for this market. Small scale bioreactors are extensively used during process and product development phases by companies to optimize fermentation conditions before commercial scale-up. Growing demand for biologics and biosimilars is also propelling the growth of this market.
PEST Analysis

Political: The small scale bioreactors market is expected to witness support from the governments across regions in terms of funding and programs for research and development activities related to biopharmaceuticals manufacturing. Stringent regulations surrounding testing and commercialization of biopharmaceuticals could challenge market growth.

Economic: Rising healthcare expenditure and growing biopharmaceuticals industry are expected to drive demand for small scale bioreactors. However, high costs associated with initial setup and maintenance of bioreactors could restrain market growth.

Social: Increasing prevalence of chronic diseases and technological advancements in biopharmaceutical manufacturing are influencing research activities positively. Growing awareness on benefits of cell therapies and biopharmaceuticals in disease management would boost market growth.

Technological: Advancements in single-use bioreactor technologies, automated process control systems, and monitoring systems are supporting efficient production of biopharmaceuticals on small scale. Integration of artificial intelligence tools is also enhancing bioreactors’ functionality.

Geographical Regions with Concentrated Market Value

North America region leads the small scale bioreactors market in terms of value. Presence of large pharmaceutical companies and research institutes involved in drug discovery and development activities support market growth. Additionally, favorable funding scenarios in the US and Canada boost adoption of advanced biopharmaceutical manufacturing technologies in the region.

Fastest Growing Regional Market

Asia Pacific region is poised to witness highest growth in the small scale bioreactors market during the forecast period. Rising biopharmaceutical production in major countries like China and India, improving research infrastructure, and increasing healthcare expenditure create a high growth potential in the region. Additionally, shifting of biopharmaceutical manufacturing facilities from developed markets influence market growth positively in Asia Pacific.